Global Viral Clearance Market , By Method ( Viral Inactivation Method and Viral Removal Method), By Application (Recombinant Proteins, Blood and Blood Products, Vaccines), By End-Users (Pharmaceutical & Biotechnology Companies, Contract Research Organisations, Academic Research Institutes) - Global Industry Trends, Shares, Competitive Analysis and Segment Forecasts, 2018 to 2025

EXRAND064  |  Upcoming  |  Global  |  NA  |  Under Development

Viruses are contagious agents that have the ability to reproduce only inside the living cells of other living organism. The major concern for many biologists is viral contamination. However the major aspect of assessing the viral safety of a biopharmaceutical is to perform a viral clearance study. The mechanism used by viruses is that they attack the cell and capture the machinery to bring out their proliferation and growth. Further the infected cell then produces viral particles instead of its regular products. The main objective of such studies is to evaluate the ability of the process to clear (remove or inactivate) identified viral contaminants. Viral clearance can be performed by many methods depending on product type, technique for production, and whether it is a medical device or not. Complete viral safety is defined by complete freedom from extraneous viral agents, and it is therefore not easy to achieve complete viral clearance. On the basis of methods the viral clearance market is segmented into viral detection method, viral inactivation method and viral removal method. The most prominent viral inactivation methods are Low pH inactivation, Solvent/detergent inactivation and others. Solvent/detergent inactivation is a robust, well-established viral clearance method. All these methods are usually effective against enveloped and non-enveloped viruses.   

The various factors that drive the growth of the global virus clearance market include a strong pharmaceutical product pipeline of that will help in the development of the pharmaceutical and biotechnology industry, the rising government funding for the biotechnology and pharmaceutical industries is also a relevant factor and lastly the  invention of innovative drugs, and rise in research & development activities. Furthermore, the increased emphasis on quality control and quality assurance in the industries boost the growth of the global Virus Clearance Market.

Some of the prominent players that fuel the growth of the global viral clearance market include Wuxi Biologics, Merck KGaA, Charles River Laboratories International Inc., TEXCELL Inc., Kedrion and others. Few companies are associated with geographical expansions, new product launch, collaborations, acquisitions and mergers, with other companies such as; on 13th February 2018, Charles River Laboratories International Inc. acquired MPI Research. MPI research is a premier non-clinical contract research organization (CRO) it provides comprehensive testing services to biopharmaceutical and medical device companies worldwide. On 17th January 2018, TEXCELL had announced establishment of its new commercial subsidiary in Japan, along with this MockV solutions announces collaboration with TEXCELL N.A., MockV solutions is a biotechnology company that focuses on developing non-infectious viral clearance prediction products. TEXCELL acquired Vivo Science GmbH on 17th May 2016, Vivo Science GmbH is a German company which provides services to the pharmaceutical industry and specializes in immunogenicity and virology. 

Based on the methods, the viral clearance market has been segmented as follows:

• Viral Inactivation Method

• Viral Removal Method

• Others

Based on the applications, the viral clearance market has been segmented as follows:

• Recombinant Proteins

• Blood and Blood Products

• Vaccines 

• Others

Based on the end-use, the viral clearance market has been segmented as follows:

• Pharmaceutical & Biotechnology Companies

• Contract Research Organizations

• Academic Research Institutes

• Others

Based on the geographical regions, the viral clearance market has been segmented as follows:

• North America

o US

o Canada

• Europe

o Germany

o France

o UK

o Rest Of Europe

• Asia Pacific

o China

o Japan

o India

o Rest Of Asia Pacific

• Middle East and Africa

o Saudi Arabia 

o South Africa

o Rest Of Middle East And Africa

• Latin America

o Brazil

o Argentina

o Rest Of Latin America


1. Executive Summary

2. Global Viral Clearance  Market Overview

2.1. Market Segmentation & Scope

2.2. Product Introduction

2.3. Market Trends

2.3.1. Introduction

2.3.2. Drivers

2.3.2.1. Rapid Growth In Pharmaceutical & Biotechnological Industries 

2.3.2.2. Possibility of Cell Culture Contamination

2.3.3. Restraint

2.3.3.1. Cost and Time-Intensive Drug Development Process

2.3.4. Opportunities

2.3.4.1. Rising Investment In Research And Development Activities In Emerging Economies

2.3.4.2. Increasing Pharmaceutical Outsourcing

2.3.5. Supply Chain Analysis

2.3.6. Substitutes Threat

2.3.7. Technology Progress in Related Industry

2.3.8. Consumer Preference Analysis

3. Global Viral Clearance  Market by Method

3.1. Viral Clearance  Market Method Analysis

3.2. Global Viral Clearance  Market Revenue (USD Million) by Methods, 2015-2025

3.3. Global Viral Clearance  Market (Revenue) by Method, 2015-2025

3.3.1. Viral Removal Viral Clearance  Market Analysis

3.3.1.1. Chromatography Viral Clearance  Market Analysis

3.3.1.2. Nanofiltration Viral Clearance  Market Analysis

3.3.1.3. Precipitation Viral Clearance  Market Analysis

3.3.2. Viral Inactivation Viral Clearance  Market Analysis

3.3.2.1. Low pH Viral Clearance  Market Analysis

3.3.2.2. Solvent Detergent Method Viral Clearance  Market Analysis

3.3.2.3. Pasteurization Viral Clearance  Market Analysis

3.3.3. Other Viral Clearance  Market Analysis

3.4. List of Manufacturers, By  Viral Clearance s Method

4. Global Viral Clearance  Market by Application

4.1. Viral Clearance  Market Application Analysis

4.2. Global Viral Clearance  Market Revenue (USD Million) by Application, 2015-2025

4.3. Global Viral Clearance  Market (Revenue), by Application, 2015-2025

4.3.1. Recombinant Protein Market Analysis

4.3.2. Blood and Blood Products Market Analysis

4.3.3. Vaccines Market Analysis

4.3.4. Other Applications Market Analysis

4.4. List of Manufacturers, By Viral Clearance  Application

5. Global Viral Clearance  Market by End Use

5.1. Viral Clearance  Market End Use Analysis

5.2. Global Viral Clearance  Market Revenue (USD Million) by End Use, (2015-2025)

5.3. Global Viral Clearance  Market (Revenue), By End Use, 2015-2025

5.3.1. Pharmaceutical & Biotechnology Companies Segment Analysis

5.3.2. Contract Research Organizations Segment Analysis

5.3.3. Academic Research Institutes Segment Analysis

5.3.4. Others Segment Analysis

5.4. List of Manufacturers, By End Use

6. Global Viral Clearance  Market by Region

6.1. Viral Clearance  Market Regional Analysis

6.2. Global Viral Clearance  Market Revenue (USD Million) by Region, 2015-2025

6.3. Global Viral Clearance  Market (Revenue), 2015-2025

7. North America Viral Clearance  Market

7.1. North America Viral Clearance  Market Analysis

7.2. North America Viral Clearance  by Country (Revenue) by Country, 2015-2025

7.2.1. U.S. Viral Clearance  Market (Revenue), 2015-2025

7.2.2. Canada Viral Clearance  Market (Revenue), 2015-2025

7.3. Potential Buyers In North America

8. Europe Viral Clearance  Market

8.1. Europe Viral Clearance  Market Analysis

8.2. Europe Viral Clearance  Market (Revenue), 2015-2025

8.3. Europe Viral Clearance  Market by Country (Revenue), 2015-2025

8.3.1. Germany Viral Clearance  Market (Revenue), 2015-2025

8.3.2. UK Viral Clearance  Market (Revenue), 2015-2025

8.3.3. France Viral Clearance  Market (Revenue), 2015-2025

8.3.4. Rest of Europe Viral Clearance  Market (Revenue), 2015-2025

8.4. Potential Buyers in Europe

9. Asia Pacific Viral Clearance  Market

9.1. Asia Pacific Viral Clearance  Market Analysis

9.2. Asia Pacific Viral Clearance  Market (Revenue), 2015-2025

9.3. Asia Pacific Viral Clearance  Market, by Country (Revenue), 2015-2025

9.3.1. China Viral Clearance  Market (Revenue), 2015-2025

9.3.2. Japan Viral Clearance  Market (Revenue), 2015-2025

9.3.3. India Viral Clearance  Market (Revenue), 2015-2025

9.3.4. Rest of Asia Pacific Viral Clearance  Market (Revenue), 2015-2025

9.4. Potential Buyers in Asia Pacific

10. Latin America Viral Clearance  Market

10.1. Latin America Viral Clearance  Market Analysis

10.2. Latin America Viral Clearance  Market (Revenue), 2015-2025

10.3. Latin America Viral Clearance  Market by Country, (Revenue, (2015-2025)

10.3.1. Brazil Viral Clearance  Market (Revenue), 2015-2025

10.3.2. Rest of Latin America Viral Clearance  Market (Revenue), 2015-2025

10.4. Potential Buyers in Latin America

11. Middle East & Africa Viral Clearance  Market

11.1. Middle East & Africa Viral Clearance  Market Regional analysis

11.2. Middle East & Africa Viral Clearance  Market ( Revenue)

11.2.1. Middle East & Africa Viral Clearance  Revenue by Country, (Kilo Units) 2015-2025

11.2.2. South Africa Viral Clearance  Market (Revenue), 2015-2025

11.2.3. Rest of Middle East & Africa Viral Clearance  Market (Revenue), 2015-2025

11.3. Potential Buyers in Middle East & Africa

12. Company Profile

12.1. Wuxi Biologics

12.1.1. Company Overview 

12.1.2. Financial Overview

12.1.3. Product Benchmarking

12.1.4. Key Developments

12.2. Merck KGaA

12.2.1. Company Overview 

12.2.2. Financial Overview

12.2.3. Product Benchmarking

12.2.4. Key Developments

12.3. Charles River Laboratories International Inc.

12.3.1. Company Overview 

12.3.2. Financial Overview

12.3.3. Product Benchmarking

12.3.4. Key Developments

12.4. Texcell Inc.

12.4.1. Company Overview 

12.4.2. Financial Overview

12.4.3. Product Benchmarking

12.4.4. Key Developments

12.5. Kedrion

12.5.1. Company Overview 

12.5.2. Financial Overview

12.5.3. Product Benchmarking

12.5.4. Key Developments

12.6. Vironova Biosafety

12.6.1. Company Overview 

12.6.2. Financial Overview

12.6.3. Product Benchmarking

12.6.4. Key Developments

12.7. AdvanSix

12.7.1. Company Overview 

12.7.2. Financial Overview

12.7.3. Product Benchmarking

12.7.4. Key Developments

12.8. Clean Cells

12.8.1. Company Overview 

12.8.2. Financial Overview

12.8.3. Product Benchmarking

12.8.4. Key Developments

12.9. BSL BIOSERVICE Scientific Laboratories Munich GmbH

12.9.1. Company Overview 

12.9.2. Financial Overview

12.9.3. Product Benchmarking

12.9.4. Key Developments

12.10. ViruSure GmbH

12.10.1. Company Overview 

12.10.2. Financial Overview

12.10.3. Product Benchmarking

12.10.4. Key Developments

13. Viral Clearance  Manufacturing Cost Analysis

13.1. Viral Clearance  Key Raw Applications Analysis

13.1.1. Key Raw Applications

13.1.2. Price Trend of Key Raw Applications

13.1.3. Market Concentration Rate of Raw Applications

13.1.4. Manufacturing Cost Structure

13.2. Marketing Strategy Analysis

13.2.1. Marketing Method Analysis

13.2.2. Pricing Strategy

13.2.3. Brand Strategy

13.2.4. Consumer Analysis

14. Key Insights

15. Research Methodology